FCPM III SERVICES B.V.
Q2 2025 13F Holdings
- Locationnaarden, P7
- Num holdings
8
- Value ($000)
$369,155
- Date Filed08/14/2025
- Form type13F-HR
- CIK0002013410
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
---|---|---|---|---|---|---|---|
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | $192.55 M | 52 % | 10,632,113 | ||
DYN DYNE THERAPEUTICS INC | COM | 26818M108 | $52.01 M | 14 % | 5,462,846 | ||
REPL REPLIMUNE GROUP INC | COM | 76029N106 | $36.32 M | 10 % | 3,909,696 | ||
ENGN ENGENE HOLDINGS INC | COM | 29286M105 | $35.06 M | 10 % | 9,632,561 | ||
BCYC BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | $23.99 M | 7 % | 3,452,330 | ||
ATXS ASTRIA THERAPEUTICS INC | COM | 04635X102 | $23.41 M | 6 % | 4,107,537 | ||
RAPT THERAPEUTICS INC | COM NEW | 75382E208 | $3.45 M | 1 % | 440,176 | ||
ENGNW ENGENE HOLDINGS INC | W EXP 10/31/2028 | 29286M113 | $2.36 M | 1 % | 2,878,148 |
Rows Per Page
10
- 10
- 50
- 100